CD133: beyond a cancer stem cell biomarker A Barzegar Behrooz, A Syahir, S Ahmad Journal of drug targeting 27 (3), 257-269, 2019 | 202 | 2019 |
Wnt and PI3K/Akt/mTOR survival pathways as therapeutic targets in glioblastoma A Barzegar Behrooz, Z Talaie, F Jusheghani, MJ Łos, T Klonisch, ... International journal of molecular sciences 23 (3), 1353, 2022 | 88 | 2022 |
Smart bomb AS 1411 aptamer‐functionalized/PAMAM dendrimer nanocarriers for targeted drug delivery in the treatment of gastric cancer A Barzegar Behrooz, F Nabavizadeh, J Adiban, M Shafiee Ardestani, ... Clinical and Experimental Pharmacology and Physiology 44 (1), 41-51, 2017 | 60 | 2017 |
Understanding glioblastoma biomarkers: knocking a mountain with a hammer M Hassn Mesrati, AB Behrooz, A Y. Abuhamad, A Syahir Cells 9 (5), 1236, 2020 | 59 | 2020 |
Could we address the interplay between CD133, Wnt/β-catenin, and tert signaling pathways as a potential target for glioblastoma therapy? AB Behrooz, A Syahir Frontiers in Oncology 11, 642719, 2021 | 26 | 2021 |
Apigenin-coated gold nanoparticles as a cardioprotective strategy against doxorubicin-induced cardiotoxicity in male rats via reducing apoptosis Z Sharifiaghdam, SM Amini, F Dalouchi, AB Behrooz, Y Azizi Heliyon 9 (3), 2023 | 16 | 2023 |
Tailoring drug co-delivery nanosystem for mitigating U-87 stem cells drug resistance AB Behrooz, R Vazifehmand, AA Tajudin, MJ Masarudin, Z Sekawi, ... Drug Delivery and Translational Research 12 (5), 1253-1269, 2022 | 15 | 2022 |
Integrating Multi-Omics Analysis for Enhanced Diagnosis and Treatment of Glioblastoma: A Comprehensive Data-Driven Approach A Barzegar Behrooz, H Latifi-Navid, SC da Silva Rosa, M Swiat, ... Cancers 15 (12), 3158, 2023 | 8 | 2023 |
Immunology meets bioengineering: Improving the effectiveness of glioblastoma immunotherapy Z Fekrirad, A Barzegar Behrooz, S Ghaemi, A Khosrojerdi, A Zarepour, ... Cancers 14 (15), 3698, 2022 | 8 | 2022 |
Nanotechnology-based combinatorial anti-glioblastoma therapies: moving from terminal to treatable A Barzegar Behrooz, Z Talaie, A Syahir Pharmaceutics 14 (8), 1697, 2022 | 7 | 2022 |
Traffic noise exposure increases gastric pepsin secretion in rat A Moslehi, F Nabavizadeh, M Keshavarz, N Rouhbakhsh, M Sotudeh, ... ACTA MEDICA IRANICA 54 (3), 191-195, 2016 | 7 | 2016 |
Metastatic outgrowth via the two-way interplay of autophagy and metabolism AB Behrooz, M Cordani, M Donadelli, S Ghavami Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 166824, 2023 | 6 | 2023 |
Pre-and post-treatment of α-Tocopherol on cognitive, synaptic plasticity, and mitochondrial disorders of the hippocampus in icv-streptozotocin-induced sporadic Alzheimer’s-like … F Nabavi Zadeh, M Nazari, A Amini, S Adeli, A Barzegar Behrooz, ... Frontiers in Neuroscience 17, 1073369, 2023 | 6 | 2023 |
Y Abuhamad, A., and Syahir, A.(2020). Understanding glioblastoma biomarkers: Knocking a mountain with a hammer M Hassn Mesrati, AB Behrooz Cells 9 (5), 1236, 0 | 6 | |
A, YA & Syahir, A M Hassn Mesrati, AB Behrooz Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer …, 2020 | 5 | 2020 |
Molecular mechanisms of microRNAs in glioblastoma pathogenesis AB Behrooz, H Latifi-Navid, A Nezhadi, M Świat, M Los, Z Jamalpoor, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 119482, 2023 | 4 | 2023 |
Targeting the Wnt/β-catenin signaling pathway in cancer S Patergnani, DJ Buchsbaum, GA Piazza Frontiers in Oncology 12, 1022174, 2022 | 2 | 2022 |
The Correlation Between Systemic Inflammatory Biomarkers, Tumor-Related Factors, and Survival in Glioblastoma Patients: A prognosticators Perspective AB Behrooz, A Syahir Neurology India 69 (4), 902-903, 2021 | 2 | 2021 |
Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle M Cordani, R Strippoli, F Trionfetti, AB Behrooz, C Rumio, G Velasco, ... Cancer Letters, 216661, 2024 | 1 | 2024 |
The Obesity-Autophagy-Cancer Axis: Mechanistic Insights and Therapeutic Perspectives AB Behrooz, M Cordani, A Fiore, M Donadelli, JW Gordon, DJ Klionsky, ... Seminars in Cancer Biology, 2024 | 1 | 2024 |